Radiotherapy with Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study
This journal activity provides practitioners with the knowledge in understanding whether radiotherapy when given with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors is associated with a different toxicity profile than radiotherapy alone.
Category
  • Breast Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 Certificate of Attendance
  • 1.00 SA-CME
Meta-Analysis of Trials of Partial Breast Irradiation
This Red  Journal activity provides practitioners with the knowledge needed to identify patients appropriate for PBI and counsel on efficacy and toxicity of modern techniques.
Category
  • Breast Cancer
Format
  • Journal SA-CME
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Factors Associated with Reconstruction Failure and Major Complications Following Post-Mastectomy Radiation to a Reconstructed Breast
This journal activity provides practitioners with the knowledge about standard techniques and doses for the treatment of post-mastectomy breast radiotherapy in the setting of a reconstructed breast.
Category
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Challenging Cases in Breast Cancer: Rare Breast Cancer Histologies and Presentations
This activity includes a panel of experts from breast radiation oncology, surgical oncology, medical oncology, and pathology to discuss the following rare histologies/breast cancer presentations: 1) Pleomorphic LCIS- diagnosis and differential (path) appropriate margin width (surgeon), role of ad
Category
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Gray Zone - A Bear of an Aberrant Case: Bilateral Breast Malignancies in a Woman with Previous History of Breast Radiation
The ultimate goal of radiation oncology research is to improve clinical care.  As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.  But despite our best efforts, evidence-based medicine cannot provide 1 clear
Category
  • Breast Cancer
Format
  • Gray Zone
Credits
  • 1.00 AMA PRA Category 1 Credit™
Hypofractionation for Regional Nodal Irradiation: Standard of Care or Investigational Only?
This activity will begin with a review of the data for hypofractionation of regional nodal irradiation (RNI). That review will cover patients with intact breasts, post-mastectomy without reconstruction and post-mastectomy with reconstruction.
Category
  • Breast Cancer
  • Other
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
ASTRO organized content area experts to evaluate clinical data regarding the use of partial breast RT. The experts used standardized criteria for curating and ranking the quality of evidence.
Category
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review
It is critical that the practicing radiation oncologist understand the available evidence and safety of combined ICI with radiation therapy in breast cancer treatment.
Category
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Oligometastatic Breast Cancer: Considering Patients One by One
SBRT for oligometastatic disease of mixed histologies has been shown to improve progression-free and even overall survival. A large cooperative group study recently demonstrated that there was no overall survival advantage seen when constrained to breast cancer alone.
Category
  • SBRT
  • Breast Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Science Highlights 2023: Breast Cancer
This session highlights the most clinically relevant abstracts within the Breast Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Breast Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 Certificate of Attendance